Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultralow Dose PSMA PET Imaging for Prostate Cancer
NCT06904313Phase 2Recruiting
- Sponsor
- Akiva Mintz
- Start
- May 2025
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Akiva Mintz. Started May 2025; status: recruiting.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06904313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06904313.